Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Friday, February 20th, 2026, at 09.00 a.m. CET. Xbrane will publish the company’s Year-end report 2025, on Friday, February 20, 2026, at 8.00 a.m. CET.
Martin Åmark, CEO, and Jane Benyamin, CFO/IR, will present the interim Year-end report 2025, followed by a Q&A session. The presentation will be in English.
If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
Q4 Report 2025
If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
Call Access